The economic impact of psychotherapy: A review

American Journal of Psychiatry

Volumn 154, Issue 2, 1997, Pages 147-155

  Gabbard, Glen O ^a,b,c   Lazar, Susan G ^a   Hornberger, John ^a   Spiegel, David ^a  

^a MENNINGER CLINIC   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; COST CONTROL; HOSPITAL COST; HUMAN; MENTAL DISEASE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW;

EID: 0031018018     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.2.147     Document Type: Review

References (47)

1. Mumford E, Schlesinger HJ, Glass GV, Patrick C, Cuerdon T: A new look at evidence about reduced cost of medical utilization following mental health treatment. Am J Psychiatry 1984; 141: 1145-1158
2. Krupnick JL, Pincus HA: The cost-effectiveness of psychotherapy: a plan for research. Am J Psychiatry 1992; 149:1295-1305
3. Manning WG Jr, Wells KG, Duan N, Newhouse JP, Ware JE Jr: How cost sharing affects the use of ambulatory mental health services. JAMA 1986; 256:1930-1934
4. Wells KB, Sturm R: Care for depression in a changing environment. Health Affairs 1995; 14:78-89
5. McGrath G, Lowson K: Assessing the benefits of psychotherapy: the economic approach. Br J Psychiatry 1986; 150:65-71
6. Frank E, Kupfer DJ, Perel JM, Cornes C, Jarrett DB, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ: Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990; 47:1093-1099
7. Frank E, Kupfer DJ, Wagner EF, McEachran AB, Cornes C: Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression. Arch Gen Psychiatry 1991; 48: 1053-1059
8. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
9. Raskin A, Schulterbrandt J, Reatig N, McKeon JJ: Replication of factors of psychopathology in interview, ward behavior and self-report ratings of hospitalized depressives. J Nerv Ment Dis 1969; 148:87-98
10. Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilkonis PA, Leber WR, Docherty JP, Feister SJ, Parloff MB: National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch Gen Psychiatry 1989; 46:971-982
11. Leff J, Berkowitz R, Shavit N, Strachan A, Glass I, Vaughn C: A trial of family therapy versus a relatives' group for schizophrenia: two-year follow-up. Br J Psychiatry 1990; 157:571-577
12. Leff J, Kuipers L, Berkowitz R, Sturgeon D: A controlled trial of social intervention in the families of schizophrenic patients: two-year follow-up. Br J Psychiatry 1985; 146:594-600
13. Leff J, Berkowitz R, Shavit N, Strachan A, Glass I, Vaughn C: A trial of family therapy vs a relatives' group for schizophrenia. Br J Psychiatry 1989; 154:58-66
14. Glick ID, Clarkin JF, Spencer JH Jr, Haas GL, Lewis AB, Peyser J, DeMane N, Good-Ellis M, Harris E, Lestelle V: A controlled evaluation of inpatient family intervention, I: preliminary results of the six-month follow-up. Arch Gen Psychiatry 1985; 42:882-886
15. Glick ID, Spencer JH Jr, Clarkin JF, Haas GL, Lewis AB, Peyser J, DeMane N, Good-Ellis M, Harris E, Lestelle V: A randomized clinical trial of inpatient family intervention, IV: follow-up results for subjects with schizophrenia. Schizophr Res 1990; 3: 187-200
16. Glick ID, Clarkin JF, Haas GL, Spencer JH Jr: Clinical significance of inpatient family intervention: conclusions from a clinical trial. Hosp Community Psychiatry 1993; 44:869-873
17. Spencer JH Jr, Glick ID, Haas GL, Clarkin JF, Lewis AB, Peyser J, DeMane N, Good-Ellis M, Harris E, Lestelle V: A randomized clinical trial of inpatient family intervention, III: effects at 6-month and 18-month follow-ups. Am J Psychiatry 1988; 145: 1115-1121
18. Clarkin JF, Glick ID, Haas GL, Spencer JH, Lewis AB, Peyser J, DeMane N, Good-Ellis M, Harris E, Lestelle V: A randomized clinical trial of inpatient family intervention, V: results for affective disorders. J Affect Disord 1990; 18:17-28
19. O'Rourke K, Detsky AS: Meta-analysis in medical research: strong encouragement for higher quality in individual research efforts. J Clin Epidemiol 1989; 42:1021-1024
20. L'Abbé KA, Detsky AS, O'Rourke K: Meta-analysis in clinical research. Ann Intern Med 1987; 107:224-233
21. Scott AIF, Freeman CPL: Edinburgh primary care depression study: treatment outcome, patient satisfaction, and cost after 16 weeks. BMJ 1992; 304:883-887
22. Falloon IRH, McGill CW, Boyd JL, Pederson J: Family management in the prevention of morbidity of schizophrenia: social outcome of a two-year longitudinal study. Psychol Med 1985; 17: 59-66
23. Liberman RP, Cardin V, McGill CW, Falloon IRH, Evans CD: Behavioral family management of schizophrenia: clinical outcome and costs. Psychiatr Annals 1987; 17:610-619
24. Spiegel D, Wissler T: Using family consultation as psychiatric aftercare for schizophrenic patients. Hosp Community Psychiatry 1987; 38:1096-1099
25. Tarrier N, Barrowclough C, Vaughn C, Bamrah JS, Porceddu K, Watts S, Freeman H: Community management of schizophrenia: a two-year follow-up of a behavioural intervention with families. Br J Psychiatry 1989; 154:625-628
26. Tarrier N, Lowson K, Barrowclough C: Some aspects of family interventions in schizophrenia, II: financial considerations. Br J Psychiatry 1991; 159:481-484
27. Hogarty GE, Anderson CM, Reiss DJ, Kornblith SJ, Greenwald DP, Ulrich RF, Carter M: Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia, II: two-year effects of a controlled study on relapse and adjustment. Environmental-Personal Indicators in the Course of Schizophrenia (EPICS) Research Group. Arch Gen Psychiatry 1991; 48:340-347
28. Vaughan K, Doyle M, McConaghy N, Blaszczynski A, Fox A, Tarrier N: The Sydney intervention trial: a controlled trial of relatives' counseling to reduce schizophrenic relapse. Soc Psychiatry Psychiatr Epidemiol 1992; 27:16-21
29. Zhang M, Wang M, Li J, Phillips M: Randomized-control trial of family interventions for 78 first-episode male schizophrenic patients: an 18-month study in Suzhou, Jiangsu. Br J Psychiatry 1994; 165(suppl):96-102
30. Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL: Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry 1991; 48:1060-1064
31. Linehan MM, Heard HL, Armstrong HE: Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Arch Gen Psychiatry 1993; 50:971-974
32. Ginsberg G, Marks I, Waters H: Cost-benefit analysis of a controlled trial of nurse therapy for neuroses in primary care. Psychol Med 1984; 14:683-690
33. McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP: The effects of psychosocial services in substance abuse treatment. JAMA 1993; 269:1953-1959
34. Retzer A, Simon FB, Weber G, Stierlin H, Schmidt G: A followup study of manic-depressive and schizoaffective psychoses after systemic family therapy. Fam Process 1991; 30:139-153
35. Verbosky LA, Franco KN, Zrull JP: The relationship between depression and length of stay in the general hospital patient. J Clin Psychiatry 1993; 54:177-181
36. Haakenaasen K, Ugelstad E: What is effective in the psychosocial treatment of younger, chronic schizophrenic inpatients? a 10 year follow-up study. Nord Psychiatr Tidssk 1986; 40:255-265
37. Lehtinen K: Need-adapted treatment of schizophrenia: a five-year follow-up study from the Turku project. Acta Psychiatr Scand 1993; 87:96-101
38. Rund BR, Moe L, Sollien T, Fjell A, Borchgrevink T, Hallert M, Næss PO: The Psychosis Project: outcome and cost-effectiveness of a psychoeducational treatment programme for schizophrenic adolescents. Acta Psychiatr Scand 1994; 89:211-218
39. Stevenson J, Meares R: An outcome study of psychotherapy for patients with borderline personality disorder. Am J Psychiatry 1992; 149:358-362
40. Klarreich SH, DiGiuseppe R, DiMattia DJ: Cost effectiveness of an employee assistance program with rational-emotive therapy. Professional Psychol 1987; 18:140-144
41. Finney JW, Riley AW, Cataldo MF: Psychology in primary health care: effects of brief targeted therapy on children's medical care utilization. J Pediatr Psychol 1990; 16:447-461
42. Heard HL: Behavior therapies for borderline patients, in CME Syllabus and Proceedings Summary, 147th Annual Meeting of the American Psychiatric Association. Washington, DC, APA, 1994
43. McFarlane WR, Lukens E, Link B: Multiple-family groups and psychoeducation in the treatment of schizophrenia. Arch Gen Psychiatry 1995; 52:679-687
44. Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, Berry S, Greenfield S, Ware J: The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 1989; 262:914-919
45. Kamlet MS, Wade M, Kupfer DJ, Frank E: Cost-utility analysis of maintenance treatment for recurrent depression: a theoretical framework and numerical illustration, in Economics and Mental Health. Edited by Frank RG, Manning WG Jr. Baltimore, Johns Hopkins University Press, 1992, pp 267-291
46. O'Brien B: Principles of economic evaluation for health care programs. J Rheumatol 1995; 22:1399-1402
47. Hornberger JC, Brown BW Jr, Halpern J: Designing a cost-effective clinical trial. Stat Med 1995; 14:2249-2259